Aspirin for the Prophylaxis of Venous Thromboembolic Events in Orthopedic Surgery Patients: A Comparison of the AAOS and ACCP Guidelines with Review of the Evidence

@article{Stewart2013AspirinFT,
  title={Aspirin for the Prophylaxis of Venous Thromboembolic Events in Orthopedic Surgery Patients: A Comparison of the AAOS and ACCP Guidelines with Review of the Evidence},
  author={David W. Stewart and Jessica E. Freshour},
  journal={Annals of Pharmacotherapy},
  year={2013},
  volume={47},
  pages={63 - 74}
}
BACKGROUND The American Academy of Orthopaedic Surgeons (AAOS) and the American College of Chest Physicians (ACCP) have both developed evidence-based guidelines to prevent venous thromboembolism (VTE) in high-risk orthopedic surgery patients. Recent changes to these documents have brought them into agreement as to the inclusion of aspirin as an appropriate option for VTE prophylaxis in this patient population. OBJECTIVE To evaluate the appropriateness of aspirin to prevent VTE in high-risk… 

Tables from this paper

Aspirin for prevention of venous thromboembolism in recipients of major lower-limb orthopaedic surgery: a systematic review of level I evidence.

Aspirin may be a viable alternative to established thromboprophylactic regimes for primary prevention of VTE, however in the setting of secondary prevention it is generally less efficacious.

Evaluation of Pharmacologic Strategies for Prevention of Venous Thromboembolism in Elective Orthopedic Surgery

There has been an increase in the use of aspirin at a tertiary academic medical center in postoperative orthopedic surgery patients withoutAn increase in DOAC use and no difference was detected in safety and efficacy endpoints in warfarin versus aspirin patients.

Review of Therapeutic Options for the Prevention of VTE in Total Joint Arthroplasty

Current literature supports the use of oral aspirin regimens in place of more aggressive anticoagulants, particularly among low risk patients, and available evidence does not demonstrate clear superiority among current options, all of which may place patients at a higher risk of bleeding and wound complications.

Thromboembolism prophylaxis failure rates after hip and knee arthroplasty: comparison of aspirin and anticoagulants

It is suggested that there is no difference between the efficacy of aspirin and anticoagulants for VTE prophylaxis after total hip or total knee arthroplasty.

Aspirin versus anticoagulation for prevention of venous thromboembolism major lower extremity orthopedic surgery: a systematic review and meta-analysis.

Compared with anticoagulation, aspirin may be associated with higher risk of DVT following hip fracture repair, although bleeding rates were substantially lower, and aspirin was similarly effective after lower extremity arthroplasty and may beassociated with lower bleeding risk.

Current approaches to prevention of venous thromboembolism following major orthopaedic surgery: a review of recommendations by international guidelines

The current approaches being used to reduce post hip and knee replacement incidences of VTE as recommended by various external guidelines are reviewed for benchmarking purposes in the Kenyan context.

Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study

Postoperative thromboprophylaxis with aspirin-only was not associated with a higher risk of postoperative venous thromboembolism compared with anticoagulants after hip or knee arthroplasty.

Aspirin for Prophylaxis Against Venous Thromboembolism After Orthopaedic Oncologic Surgery

Aspirin may be a suitable and effective option for VTE chemoprophylaxis in patients treated with orthopaedic oncologic surgery, especially those diagnosed with a soft-tissue sarcoma.
...

References

SHOWING 1-10 OF 52 REFERENCES

Warfarin for Venous Thromboembolism Prophylaxis After Elective Hip or Knee Arthroplasty: Exploring the Evidence, Guidelines, and Challenges Remaining

  • W. Dager
  • Medicine
    The Annals of pharmacotherapy
  • 2012
Comparing trials using vitamin K antagonists (VKAs) and differences in guidelines to determine the benefits and drawbacks of warfarin for VTE prophylaxis following THA/TKA found the incidence of bleeding tended to be lower with the use of VKAs, but thrombosis when including asymptomatic events was numerically higher when comparing INR targets.

Preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty.

  • Michael A MontJ. Jacobs Patrick Sluka
  • Medicine
    The Journal of the American Academy of Orthopaedic Surgeons
  • 2011
Early mobilization for patients following elective hip and knee arthroplasty is recommended and no clear evidence was established regarding whether inferior vena cava filters can prevent pulmonary embolism in patients who have a contraindication to chemoprophylaxis and/or known VTED.

A Meta-Analysis of Thromboembolic Prophylaxis Following Elective Total Hip Arthroplasty*

The best prophylactic agent in terms of both efficacy and safety was warfarin, followed by pneumatic compression, and the least effective and safe was low-dose heparin.

Prevention of VTE in orthopedic surgery patients

A model of budget impact, in the perspective of the Italian NHS, is built from the data related to cases of major surgical orthopedic procedures and a meta-analysis on the pivotal RCT, which aims to measure the differential effects in terms of prevention of VTE, showing that the financial impact of the NOA in the prophylaxis of major Orthopedic surgery is not particularly relevant.

Comparison of ACCP and AAOS guidelines for VTE prophylaxis after total hip and total knee arthroplasty.

Because symptomatic pulmonary embolism is rare after THA and TKA, the American Academy of Orthopaedic Surgeons has developed a clinical practice guideline focused on preventing this complication while minimizing the risk of bleeding due to pharmacologic prophylaxis.

Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

This article discusses the prevention of venous thromboembolism (VTE) and is part of the Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence-Based Clinical Practice

Aspirin in the prevention and treatment of venous thromboembolism

There is no evidence to support a role for aspirin in air travel‐related VTE, but studies are ongoing to determine the potential role of aspirin after a first unprovoked VTE.
...